Barriers and pathways to development of Indigenous traditional medicines

该项目旨在探索澳大利亚的监管系统如何更好地支持土著和托雷斯海峡岛民传统知识（TK）持有人将其传统药物商业化。该项目以mudjala植物为重点，并与金伯利的Nyikina人合作，应该产生新的人类学方法来记录与传统医学有关的传统知识，新的模式来调节传统药物产品，以及对激活该植物的传统方法的药理学见解。其他预期结果包括释放巨大的、未开发的潜力，使澳大利亚土著居民受益于由治疗用品管理局监管的传统医药产品的开发。

This project aims to explore how Australian regulatory systems can better support Aboriginal and Torres Strait Islander Traditional Knowledge (TK) holders to commercialise their traditional medicines. Focusing on the mudjala plant and working with the Kimberley’s Nyikina people, the project should generate new anthropological methods for documenting TK related to traditional medicine, new models for regulating traditional medicinal products, and pharmacological insights into traditional methods of activating the plant. Additional expected outcomes include unlocking the significant, untapped potential for Indigenous Australians to benefit from the development of traditional medicine products regulated by the Therapeutic Goods Administration.